MedPath

Nottingham University Hospitals NHS Trust

Nottingham University Hospitals NHS Trust logo
🇬🇧United Kingdom
Ownership
Private
Established
2006-01-01
Employees
10K
Market Cap
-
Website
http://www.nuh.nhs.uk

Clinical Trials

103

Active:4
Completed:50

Trial Phases

5 Phases

Phase 1:2
Phase 2:7
Phase 3:1
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (54 trials with phase data)• Click on a phase to view related trials

Not Applicable
38 (70.4%)
Phase 2
7 (13.0%)
Phase 4
6 (11.1%)
Phase 1
2 (3.7%)
Phase 3
1 (1.9%)

Implementation of Point Of Care UltraSound in the Assessment of Crohn's Disease -The POCUS Study

Terminated
Conditions
Crohn Disease of Small Intestine
First Posted Date
2025-09-05
Last Posted Date
2025-09-05
Lead Sponsor
Nottingham University Hospitals NHS Trust
Target Recruit Count
4
Registration Number
NCT07157436
Locations
🇬🇧

Nottingham NIHR Biomedical Research Centre, Nottingham, Nottinghamshire, United Kingdom

Seizure Identification on the Intensive Care Unit (ICU)

Recruiting
Conditions
Seizures
First Posted Date
2025-08-22
Last Posted Date
2025-08-22
Lead Sponsor
Nottingham University Hospitals NHS Trust
Target Recruit Count
40
Registration Number
NCT07136298
Locations
🇬🇧

Nottingham University Hospitals, Nottingham, Nottinghamshire, United Kingdom

The Feasibility and Acceptability of an Online Yoga Program for People With Functional Neurological Disorders

Not Applicable
Not yet recruiting
Conditions
Functional Neurological Disorder
Dissociative Seizures
Psychogenic Seizure
Non-Epileptic Seizure
First Posted Date
2025-07-22
Last Posted Date
2025-07-22
Lead Sponsor
Nottingham University Hospitals NHS Trust
Target Recruit Count
30
Registration Number
NCT07077603

The Impact of Treatment for Chronic Hepatitis B Virus on Non-clinical Harms

Not yet recruiting
Conditions
Hepatitis B Virus (HBV)
First Posted Date
2025-07-08
Last Posted Date
2025-07-16
Lead Sponsor
Nottingham University Hospitals NHS Trust
Target Recruit Count
30
Registration Number
NCT07053449

A Single Arm Intervention Study to Assess the Acceptability, Tolerance and Ease of Use of Wilbo's Blends+ (Commercial Enteral Feed Based on Real Food) When Used as Part of a Dietitian Prescribed Enteral Feeding Plan

Not Applicable
Not yet recruiting
Conditions
Enteral Nutrition (Food for Special Medical Purposes)
Enteral Feeds
Enteral Tube Nutrition
Gastrostomy Tube
First Posted Date
2025-06-25
Last Posted Date
2025-08-08
Lead Sponsor
Nottingham University Hospitals NHS Trust
Target Recruit Count
40
Registration Number
NCT07036081
Locations
🇬🇧

Nottingham University Hospitals NHS Trust, Nottingham, Nottinghamshire, United Kingdom

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 21
  • Next

News

Dendritic Cell Vaccine Shows Promise in Liver Cancer Trial, Extending Progression-Free Survival

The ImmunoTACE phase II trial demonstrated that patients with intermediate-stage hepatocellular carcinoma who received dendritic cell vaccination alongside standard treatment experienced significantly longer progression-free survival at 18.6 months versus 10.4 months with standard care alone.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.